联邦制药(03933)：注射用阿莫西林钠克拉维酸钾通过一致性评价

智通财经2025-07-17

智通财经APP讯，联邦制药(03933)发布公告，公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的注射用阿莫西林钠克拉维酸钾(规格：0.6g、1.2g)经中国国家药品监督管理局审批，通过仿制药质量和疗效一致性评价。注射用阿莫西林钠克拉维酸钾是一种青霉素类广谱抗生素，由阿莫西林钠(青霉素类抗生素)与克拉维酸钾(β-内酰胺酶抑制剂)组成。克拉维酸通过抑制细菌产生的β -内酰胺酶，显著增强...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2552548703?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-17 22:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2552548703","market":"hk","top_or_hot":-1,"title":"联邦制药(03933)：注射用阿莫西林钠克拉维酸钾通过一致性评价","media":"智通财经","content":"<div>\n<p>智通财经APP讯，联邦制药(03933)发布公告，公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的注射用阿莫西林钠克拉维酸钾(规格：0.6g、1.2g)经中国国家药品监督管理局审批，通过仿制药质量和疗效一致性评价。注射用阿莫西林钠克拉维酸钾是一种青霉素类广谱抗生素，由阿莫西林钠(青霉素类抗生素)与克拉维酸钾(β-内酰胺酶抑制剂)组成。克拉维酸通过抑制细菌产生的β -内酰胺酶，显著增强...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1319209.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>联邦制药(03933)：注射用阿莫西林钠克拉维酸钾通过一致性评价</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n联邦制药(03933)：注射用阿莫西林钠克拉维酸钾通过一致性评价\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-17 22:55 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1319209.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，联邦制药(03933)发布公告，公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的注射用阿莫西林钠克拉维酸钾(规格：0.6g、1.2g)经中国国家药品监督管理局审批，通过仿制药质量和疗效一致性评价。注射用阿莫西林钠克拉维酸钾是一种青霉素类广谱抗生素，由阿莫西林钠(青霉素类抗生素)与克拉维酸钾(β-内酰胺酶抑制剂)组成。克拉维酸通过抑制细菌产生的β -内酰胺酶，显著增强...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1319209.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1319209.html","article_id":"2552548703","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2552548703","pubTimestamp":1752764102,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，联邦制药 发布公告，公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的注射用阿莫西林钠克拉维酸钾经中国国家药品监督管理局审批，通过仿制药质量和疗效一致性评价。注射用阿莫西林钠克拉维酸钾是一种青霉素类广谱抗生素，由阿莫西林钠与克拉维酸钾组成。现时，注射用阿莫西林钠克拉维酸钾为国家基药目录及国家医保目录乙类药品。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1191":"制药","03933":"联邦制药"},"translate_title":"United Laboratories (03933): Amoxicillin sodium and clavulanate potassium for injection passed the consistency evaluation","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03933":1},"content_text":"智通财经APP讯，联邦制药(03933)发布公告，公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的注射用阿莫西林钠克拉维酸钾(规格：0.6g、1.2g)经中国国家药品监督管理局审批，通过仿制药质量和疗效一致性评价。注射用阿莫西林钠克拉维酸钾是一种青霉素类广谱抗生素，由阿莫西林钠(青霉素类抗生素)与克拉维酸钾(β-内酰胺酶抑制剂)组成。克拉维酸通过抑制细菌产生的β -内酰胺酶，显著增强阿莫西林对耐药菌的抗菌活性。临床适用于治疗由敏感菌引起的上呼吸道感染、下呼吸道感染、生殖泌尿道感染、皮肤及软组织感染、骨和关节感染等。现时，注射用阿莫西林钠克拉维酸钾为国家基药目录(二零一八年版)及国家医保目录(二零二四年版)乙类药品。本次获批将进一步有助于公司巩固于抗感染领域的优势地位。公司将持续致力于新产品研发及推进一致性评价，预期将为公司及其股东创造更大收益。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2552548703","isCrawlerRequest":true}